BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027

  December 12, 2025

   · 

  4 min read
• Press Releases

  Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications

  December 12, 2025

   · 

  4 min read
• Press Releases

  Neurenati Therapeutics Welcomes Dr Daniel Guay to Its Board of Directors and Dr Carlo Di Lorenzo to Its Scientific and Clinical Advisory Board

  December 12, 2025

   · 

  2 min read
• Press Releases

  GRI Bio Announces Pricing of $8,000,000 Million Public Offering

  December 12, 2025

   · 

  6 min read
• Press Releases

  Five Leading Cancer Centers Unite to Target CD123 and Eradicate Hidden Leukemia Cells

  December 12, 2025

   · 

  4 min read
• Press Releases

  NCCN Awards Grants to Improve Care for People with Metastatic Breast Cancer (mBC)

  December 12, 2025

   · 

  4 min read
• Press Releases

  Gerosynth Labs Announces Investigational New Animal Drug (INAD) Acceptances Spanning Equine, Feline, and Canine Oncology

  December 12, 2025

   · 

  3 min read
• Press Releases

  NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review

  December 12, 2025

   · 

  2 min read
• Press Releases

  Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

  December 12, 2025

   · 

  7 min read
• Press Releases

  NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025

  December 12, 2025

   · 

  3 min read